MONECO Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Hold |
7,505
| – | – | 0.07% | 221 |
|
|
2025
Q1 | $875K | Sell |
7,505
-8
| -0.1% | -$933 | 0.09% | 193 |
|
|
2024
Q4 | $636K | Buy |
7,513
+48
| +0.6% | +$4.06K | 0.07% | 239 |
|
|
2024
Q3 | $671K | Sell |
7,465
-20
| -0.3% | -$1.8K | 0.08% | 205 |
|
|
2024
Q2 | $603K | Hold |
7,485
| – | – | 0.09% | 209 |
|
|
2024
Q1 | $597K | Hold |
7,485
| – | – | 0.09% | 219 |
|
|
2023
Q4 | $596K | Hold |
7,485
| – | – | 0.11% | 197 |
|
|
2023
Q3 | $523K | Hold |
7,485
| – | – | 0.14% | 167 |
|
|
2023
Q2 | $538K | Sell |
7,485
-615
| -8% | -$44.2K | 0.15% | 164 |
|
|
2023
Q1 | $500K | Buy |
8,100
+100
| +1% | +$6.17K | 0.15% | 160 |
|
|
2022
Q4 | $617K | Sell |
8,000
-100
| -1% | -$7.71K | 0.22% | 112 |
|
|
2022
Q3 | $361K | Sell |
8,100
-830
| -9% | -$37K | 0.14% | 156 |
|
|
2022
Q2 | $342K | Hold |
8,930
| – | – | 0.13% | 162 |
|
|
2022
Q1 | $370K | Hold |
8,930
| – | – | 0.14% | 151 |
|
|
2021
Q4 | $241K | Buy |
8,930
+500
| +6% | +$13.5K | 0.09% | 209 |
|
|
2021
Q3 | $278K | Buy |
+8,430
| New | +$278K | 0.11% | 192 |
|